ArticleMolecular cancer therapeutics2020

Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma.

Bih-Rong Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.